Development And Validation Of New Stability Indicating Method For Assay Of Pitavastatin In Solid Oral Dosage Form.

Article Sidebar

pdf
Published: Jun 18, 2022
DOI: https://doi.org/10.53555/sfs.v8i3.1911
Keywords:
Pitavastatin RP-HPLC Analytical techniques Validation stability-indicating analysis

Main Article Content

Jeevan Patel
Manmeet Singh Saluja

Abstract

To explore recent advancements in HPLC instrumentation and column technology for stability-indicating analysis. Pitavastatin (PVS) is a synthetic competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase and a very effective lipid-lowering medication. Aim of this study was to develop, optimize and validate novel stability-indicating RP-HPLC methods for Pitavastatin in solid oral dosage forms.

Article Details

Issue
Volume 8 - Issue 3 (2022)
Section
Articles
Author Biographies

Jeevan Patel

Research Scholars, Department of Pharmacy, Monad University, Hapur, Uttar Pradesh

Manmeet Singh Saluja

Professor, Department of Pharmacy, Monad University, Hapur, Uttar Pradesh